Merger Notification - Announcement according to § 10 Cartel Act
iNova Pharmaceuticals (Singapore) Pte Limited; Mundipharma Gesellschaft m.b.H.
BWB/Z-6329
On 25.07.2023 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
iNova Pharmaceuticals (Singapore) Pte Limited, Singapore, intends to acquire Mundipharma's consumer healthcare business in a number of countries. The acquisition will be implemented through two sale and purchase agreements: one for Australia and New Zealand and another for the remainder of the relevant countries.
Economic Sector: Wholesale of pharmaceutical products.
Industry sector: G - Handel; Instandhaltung und Reparatur von Kraftfahrzeugen
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 22.08.2023.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 23.08.2023 .